Harvey Berger | BiotechTV

top of page

Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech

Biotech industry veteran Harvery Berger talks about his company's job at hand to translate the science of ferroptosis into therapies....

The Studio at Kendall Square

Oct 25, 2024

Biotech veteran Harvey Berger on why he joined Kojin Therapeutics

Harvey Berger describes the science of ferroptosis and his experience working with Kojin's scientific founder Stuart Schreiber.

Company News

Jan 10, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech

Biotech veteran Harvey Berger on why he joined Kojin Therapeutics

Follow BiotechTV

Sponsors

Sponsor Spotlight